the chemotherapeutic regimen was based on the cyclic administration of two noncross-resistant cytotoxic combinations : cmfv ( cyclophosphamide 300 mg/m2 i.v. , days 1 and 5 ; methotrexate , 20 mg/m2 i.v. , days 1 and 4 ; 5-fluorouracil 325 mg/m2 i.v. , days 1-5 ; vincristine 0.75 mg/m2 i.v. , days 2 and 5 ) and ac ( adriamycin 40 mg/m2 i.v. , day 1 ; cyclophosphamide 200 mg/m2 i.v. , days 3-5 ) every 4-5 weeks .
C0056159
cmfv
C0025677
methotrexate